UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection

Frontiers in immunology, 2016-12, Vol.7, p.585-585

Rajalingam, Raja

2016

Volltextzugriff (PDF)

Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease

Clinics in laboratory medicine, 2018-12, Vol.38 (4), p.637-653

Rajalingam, Raja, PhD

2018

Volltextzugriff (PDF)

Overview of the killer cell immunoglobulin-like receptor system

Methods in molecular biology (Clifton, N.J.), 2012, Vol.882, p.391

Rajalingam, Raja

2012

Volltextzugriff (PDF)

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Blood, 2019-09, Vol.134 (12), p.924-934

2019

Volltextzugriff (PDF)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

Journal of pharmacological sciences, 2023-05, Vol.152 (1), p.1-21

2023

Volltextzugriff (PDF)

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

The Journal of experimental medicine, 2018-01, Vol.215 (1), p.141-157

2018

Volltextzugriff (PDF)

The genomic landscape of the immune system in lung cancer: present insights and continuing investigations

Frontiers in genetics, 2024-06, Vol.15, p.1414487

2024

Volltextzugriff (PDF)

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

Nature biotechnology, 2019-10, Vol.37 (10), p.1137-1144

2019

Volltextzugriff (PDF)

KIR-HLA gene diversities and susceptibility to lung cancer

Scientific reports, 2022-10, Vol.12 (1), p.17237-17237, Article 17237

2022

Volltextzugriff (PDF)

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations

Scientific reports, 2023-02, Vol.13 (1), p.2351-2351, Article 2351

2023

Volltextzugriff (PDF)

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2268-2278

2017

Volltextzugriff (PDF)

Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19

Frontiers in genetics, 2022-02, Vol.13, p.845474-845474

2022

Volltextzugriff (PDF)

Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects

Frontiers in cell and developmental biology, 2022-03, Vol.10, p.664261

2022

Volltextzugriff (PDF)

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

Cell reports (Cambridge), 2023-07, Vol.42 (7), p.112682-112682, Article 112682

2023

Volltextzugriff (PDF)

De novo and recurrent post-transplant membranous nephropathy cases show similar rates of concurrent antibody-mediated rejection

Frontiers in Nephrology (Online), 2024-09, Vol.4

2024

Volltextzugriff (PDF)

Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals

PloS one, 2012-11, Vol.7 (11), p.e47491-e47491

2012

Volltextzugriff (PDF)

Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease

Stem cell reports, 2019-08, Vol.13 (2), p.254-261

2019

Volltextzugriff (PDF)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

PloS one, 2016-06, Vol.11 (6), p.e0158242-e0158242

2016

Volltextzugriff (PDF)

Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells

PLoS genetics, 2010-11, Vol.6 (11), p.e1001192-e1001192

2010

Volltextzugriff (PDF)

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease

PloS one, 2016-08, Vol.11 (8), p.e0160392-e0160392

2016

Volltextzugriff (PDF)

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002958

2021

Volltextzugriff (PDF)

Allele-level HLA matching reduces early rejection in lung transplant recipients

Annals of translational medicine, 2020-03, Vol.8 (6), p.275-275

Rajalingam, Raja

2020

Volltextzugriff (PDF)

Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression

Nature biotechnology, 2023-05, Vol.41 (5), p.717-727

2023

Volltextzugriff (PDF)

Anti-HLA class I antibody–mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells

Human immunology, 2004-04, Vol.65 (4), p.291-302

2004

Volltextzugriff (PDF)

Distinctive KIR and HLA diversity in a panel of north Indian Hindus

Immunogenetics (New York), 2002-03, Vol.53 (12), p.1009-1019

2002

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(191)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(70)
Humans
(69)
Immunology
(42)
Allergy And Immunology
(29)
Female
(22)
Haplotypes
(22)
Killer Cells, Natural - Immunology
(21)
Male
(21)
Receptors, Kir - Genetics
(20)
Killer Cell Immunoglobulin-Like Receptors
(18)
Natural Killer Cells
(17)
Genotype
(15)
Transplantation
(15)
Animals
(14)
Adult
(13)
Gene Frequency
(13)
Ligands
(13)
Antigens
(12)
Alleles
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection

Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease

Overview of the killer cell immunoglobulin-like receptor system

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

The genomic landscape of the immune system in lung cancer: present insights and continuing investigations

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

KIR-HLA gene diversities and susceptibility to lung cancer

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation

Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19

Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

De novo and recurrent post-transplant membranous nephropathy cases show similar rates of concurrent antibody-mediated rejection

Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals

Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

Allele-level HLA matching reduces early rejection in lung transplant recipients

Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression

Anti-HLA class I antibody–mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells

Distinctive KIR and HLA diversity in a panel of north Indian Hindus

Suchergebnisse filtern